240 related articles for article (PubMed ID: 18590355)
1. Cortical atrophy and personality in multiple sclerosis.
Benedict RH; Hussein S; Englert J; Dwyer MG; Abdelrahman N; Cox JL; Munschauer FE; Weinstock-Guttman B; Zivadinov R
Neuropsychology; 2008 Jul; 22(4):432-41. PubMed ID: 18590355
[TBL] [Abstract][Full Text] [Related]
2. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
[TBL] [Abstract][Full Text] [Related]
3. Thalamic atrophy and cognition in multiple sclerosis.
Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
[TBL] [Abstract][Full Text] [Related]
4. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
Benedict RH; Carone DA; Bakshi R
J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758
[TBL] [Abstract][Full Text] [Related]
5. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
6. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
[TBL] [Abstract][Full Text] [Related]
7. [Psychological and neuropsychological problems in multiple sclerosis].
Béquet D; Taillia H; Clervoy P; Renard JL; Flocard F
Bull Acad Natl Med; 2003; 187(4):683-94; discussion 695-7. PubMed ID: 14556476
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
9. Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis.
Benedict RH; Schwartz CE; Duberstein P; Healy B; Hoogs M; Bergsland N; Dwyer MG; Weinstock-Guttman B; Zivadinov R
Psychosom Med; 2013 Apr; 75(3):253-61. PubMed ID: 23504242
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.
Benedict RH; Bruce J; Dwyer MG; Weinstock-Guttman B; Tjoa C; Tavazzi E; Munschauer FE; Zivadinov R
Mult Scler; 2007 Jul; 13(6):722-30. PubMed ID: 17613599
[TBL] [Abstract][Full Text] [Related]
11. Regional hippocampal atrophy in multiple sclerosis.
Sicotte NL; Kern KC; Giesser BS; Arshanapalli A; Schultz A; Montag M; Wang H; Bookheimer SY
Brain; 2008 Apr; 131(Pt 4):1134-41. PubMed ID: 18375977
[TBL] [Abstract][Full Text] [Related]
12. [Brain atrophy and cognitive disorder in multiple sclerosis].
Pál E; Kosztolányi P; Perlaky P
Orv Hetil; 2002 Dec; 143(48):2681-5. PubMed ID: 12501577
[TBL] [Abstract][Full Text] [Related]
13. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis.
Sumowski JF; Chiaravalloti N; Wylie G; Deluca J
J Int Neuropsychol Soc; 2009 Jul; 15(4):606-12. PubMed ID: 19573279
[TBL] [Abstract][Full Text] [Related]
14. T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.
Bagnato F; Salman Z; Kane R; Auh S; Cantor FK; Ehrmantraut M; Gallo A; Ikonomidou VN; Ohayon J; Pellicano C; Stern SK; McFarland HF
Mult Scler; 2010 Oct; 16(10):1203-12. PubMed ID: 20699284
[TBL] [Abstract][Full Text] [Related]
15. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS.
Carone DA; Benedict RH; Munschauer FE; Fishman I; Weinstock-Guttman B
J Int Neuropsychol Soc; 2005 Sep; 11(5):574-83. PubMed ID: 16212684
[TBL] [Abstract][Full Text] [Related]
16. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
Glanz BI; Holland CM; Gauthier SA; Amunwa EL; Liptak Z; Houtchens MK; Sperling RA; Khoury SJ; Guttmann CR; Weiner HL
Mult Scler; 2007 Sep; 13(8):1004-10. PubMed ID: 17623735
[TBL] [Abstract][Full Text] [Related]
17. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
Rovaris M; Comi G; Filippi M
J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
[TBL] [Abstract][Full Text] [Related]
18. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis.
Tekok-Kilic A; Benedict RH; Weinstock-Guttman B; Dwyer MG; Carone D; Srinivasaraghavan B; Yella V; Abdelrahman N; Munschauer F; Bakshi R; Zivadinov R
Neuroimage; 2007 Jul; 36(4):1294-300. PubMed ID: 17524670
[TBL] [Abstract][Full Text] [Related]
19. Domain and facet personality predictors of all-cause mortality among Medicare patients aged 65 to 100.
Weiss A; Costa PT
Psychosom Med; 2005; 67(5):724-33. PubMed ID: 16204430
[TBL] [Abstract][Full Text] [Related]
20. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.
Benedict RH; Wahlig E; Bakshi R; Fishman I; Munschauer F; Zivadinov R; Weinstock-Guttman B
J Neurol Sci; 2005 Apr; 231(1-2):29-34. PubMed ID: 15792817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
